122 related articles for article (PubMed ID: 15646840)
1. Clinical significance of urinary N1,N12-diacetylspermine levels in patients with hepatocellular carcinoma.
Enjoji M; Nakamuta M; Arimura E; Morizono S; Kuniyoshi M; Fukushima M; Kotoh K; Nawata H
Int J Biol Markers; 2004; 19(4):322-7. PubMed ID: 15646840
[TBL] [Abstract][Full Text] [Related]
2. [Urinary diacetylspermine: its analysis and performance as a novel tumor marker].
Kawakita M; Hiramatsu K; Takahashi K; Yamada R; Kawaguchi M; Shinoura N; Tanaka T; Kariyone K; Tamamori Y; Sasaki Y; Mori T
Rinsho Byori; 2005 Feb; 53(2):123-9. PubMed ID: 15796045
[TBL] [Abstract][Full Text] [Related]
3. [Establishment of an ELISA system of N1,N12-diacetylspermine in human urine].
Matsuoka A; Sakamoto T
Rinsho Byori; 2004 Apr; 52(4):328-31. PubMed ID: 15164600
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of urine N1,N12-Diacetylspermine as potential tumor marker for urinary bladder cancer.
Stejskal D; Humenanska V; Hanulova Z; Fiala R; Vrtal R; Solichova P; Karpisek M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Nov; 150(2):235-7. PubMed ID: 17426784
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
[TBL] [Abstract][Full Text] [Related]
6. Development of a sensitive and accurate enzyme-linked immunosorbent assay (ELISA) system that can replace HPLC analysis for the determination of N1,N12-diacetylspermine in human urine.
Hiramatsu K; Miura H; Kamei S; Iwasaki K; Kawakita M
J Biochem; 1998 Jul; 124(1):231-6. PubMed ID: 9644268
[TBL] [Abstract][Full Text] [Related]
7. [Clinical usefulness of urinary diacetylpolyamines as novel tumor markers].
Kawakita M; Hiramatsu K; Sugimoto M; Takahashi K; Toi M
Rinsho Byori; 2004 Apr; 52(4):321-7. PubMed ID: 15164599
[TBL] [Abstract][Full Text] [Related]
8. Excretion of N(1), N(12)-diacetylspermine in the urine of healthy individuals.
Hiramatsu K; Sakaguchi K; Fujie N; Saitoh F; Takahama E; Moriya SS; Iwasaki K; Sakaguchi M; Takahashi K; Kawaikta M
Ann Clin Biochem; 2014 Jul; 51(Pt 4):459-67. PubMed ID: 23963052
[TBL] [Abstract][Full Text] [Related]
9. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
Feng H; Li B; Li Z; Wei Q; Ren L
BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
[TBL] [Abstract][Full Text] [Related]
10. Significant correlation between urinary N(1), N(12)-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancer.
Takahashi Y; Horio H; Sakaguchi K; Hiramatsu K; Kawakita M
BMC Cancer; 2015 Feb; 15():65. PubMed ID: 25884987
[TBL] [Abstract][Full Text] [Related]
11. Diacetylated derivatives of spermine and spermidine as novel promising tumor markers.
Kawakita M; Hiramatsu K
J Biochem; 2006 Mar; 139(3):315-22. PubMed ID: 16567395
[TBL] [Abstract][Full Text] [Related]
12. Increase of N1, N12-diacetylspermine in tissues from colorectal cancer and its liver metastasis.
Kuwata G; Hiramatsu K; Samejima K; Iwasaki K; Takahashi K; Koizumi K; Horiguchi S; Moriya SS; Kobayashi M; Kawakita M
J Cancer Res Clin Oncol; 2013 Jun; 139(6):925-32. PubMed ID: 23443255
[TBL] [Abstract][Full Text] [Related]
13. Determination of amounts of polyamines excreted in urine: demonstration of N1,N8-diacetylspermidine and N1,N12-diacetylspermine as components commonly occurring in normal human urine.
Hiramatsu K; Sugimoto M; Kamei S; Hoshino M; Kinoshita K; Iwasaki K; Kawakita M
J Biochem; 1995 Jan; 117(1):107-12. PubMed ID: 7775374
[TBL] [Abstract][Full Text] [Related]
14. Urinary N
Yokota K; Hinoki A; Hiramatsu K; Amano H; Kawamura M; Kuwatsuka Y; Tainaka T; Shirota C; Sumida W; Makita S; Okamoto M; Takimoto A; Yasui A; Nakagawa Y; Uchida H; Kawakita M
Pediatr Surg Int; 2021 Dec; 37(12):1659-1665. PubMed ID: 34453590
[TBL] [Abstract][Full Text] [Related]
15. Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients.
Viggiani V; Palombi S; Gennarini G; D'Ettorre G; De Vito C; Angeloni A; Frati L; Anastasi E
Scand J Gastroenterol; 2016 Oct; 51(10):1257-62. PubMed ID: 27227515
[TBL] [Abstract][Full Text] [Related]
16. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers.
Hiramatsu K; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H; Tanaka S; Tanaka C; Tamamori Y; Imajo M; Kawaguchi M; Toi M; Mori T; Kawakita M
Clin Cancer Res; 2005 Apr; 11(8):2986-90. PubMed ID: 15837752
[TBL] [Abstract][Full Text] [Related]
17. Plasma abnormal prothrombin (PIVKA-II): a new and reliable marker for the detection of hepatocellular carcinoma.
Takikawa Y; Suzuki K; Yamazaki K; Goto T; Madarame T; Miura Y; Yoshida T; Kashiwabara T; Sato S
J Gastroenterol Hepatol; 1992; 7(1):1-6. PubMed ID: 1371940
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the utility of N1,N12-diacetylspermine and N1,N8-diacetylspermidine in urine as tumor markers for breast and colorectal cancers.
Umemori Y; Ohe Y; Kuribayashi K; Tsuji N; Nishidate T; Kameshima H; Hirata K; Watanabe N
Clin Chim Acta; 2010 Dec; 411(23-24):1894-9. PubMed ID: 20655890
[TBL] [Abstract][Full Text] [Related]
19. Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma.
Ricco G; Cosma C; Bedogni G; Biasiolo A; Guarino M; Pontisso P; Morisco F; Oliveri F; Cavallone D; Bonino F; Plebani M; Brunetto MR
Cancer Biomark; 2020; 29(2):189-196. PubMed ID: 32623383
[TBL] [Abstract][Full Text] [Related]
20. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]